期刊文献+

人用狂犬病毒脂质体疫苗的制备及性质 被引量:2

Preparation and Property of Rabies Virus Liposome Vaccine for Human Use
下载PDF
导出
摘要 目的制备人用狂犬病毒脂质体疫苗,并考察其制剂学及毒理学性质。方法以氢化大豆磷脂、胆固醇、十八胺为原料,采用反相蒸发法(REV)制备脂质体,加入纯化狂犬病毒抗原,以冻干重建法(DRV)制备狂犬病毒脂质体疫苗。在电镜下观察其形态,测定其包封率和体外释放率,用激光衍射粒度分析仪测定其粒径分布及平均粒径,并进行局部刺激性、过敏反应及异常毒性试验。结果所制备的狂犬病毒脂质体疫苗形态呈圆形或椭圆形,粒径分布均匀,平均粒径为12.25μm左右,包封率在60%以上。无刺激性,无异常毒性,过敏反应检测合格。结论所制备的狂犬病毒脂质体疫苗性质稳定,可作进一步研究。 Objective To prepare the rabies virus liposome vaccine for human use and explore its pharmaceutical and toxicological properties. Methods Prepare liposome with phospholipid,cholesterol and stearylamine by reverse evaporation ,then add purified rabies virus antigen for preparation of rabies virus liposome vaccine by lyophilization. Observe the prepared vaccine for morphology under electron microscope, and determine for envelope rate and release in vitro. Analyze the particale distribution and size of the vaccine by laser diffraction particle size analyzer. Perform local stimulation, hypersensitivity and abnormal toxicity tests on the prepared vaccine. Results The prepared rabies virus liposome vaccine under electron microscope were in forms of round or elliptic particles distributed evenly,at a mean size of 12. 25 μm. The envelope rate of the vaccine was more than 60%. The vaccine showed no stimulation or abnormal toxicity and was qualified in hypersensitivity test. Conclusion The prepared rabies virus liposome vaccine showed stable property and was value of further study.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第6期589-591,共3页 Chinese Journal of Biologicals
关键词 狂犬病毒 脂质体疫苗 性质 Rabies virus Liposome vaccine Property
  • 相关文献

参考文献2

  • 1Gregoriadis G,Tan L,Ben-Ahmeida ET,et al.Liposomes enhance the immunogenicity of reconstituted influenza vinus A/PR/8/envelopes and the formation of protective antibody by influenIa virus A/Sichuam/87 (H3N2) surface antigen.Vaccine,1992,10 (11):747-753.
  • 2Nigel PC,Andrew E.Enhanced antibody response to Liposome-associated protein antigens:preferential stimulation of IgG 2a/b production.Vaccine,1992,10(3):151-158.

同被引文献21

  • 1武长城,李兰英,张栋,宋惠.丁二酸单胆固醇酯的合成研究[J].天津工业大学学报,2005,24(6):27-29. 被引量:10
  • 2程建峰,扈本荃,刘梅,贺建荣,扬胜,王弼时.甘草酸脂质体的处方及制备工艺[J].第四军医大学学报,2006,27(7):655-657. 被引量:8
  • 3傅克勤,胡承阅.脂质体疫苗抗原缓释系统[J].国外医学(计划生育.生殖健康分册),2006,25(4):218-221. 被引量:1
  • 4郝淑美,王亚军,戚凤春,李洪广.脂质体流感疫苗制备及体液免疫应答的研究[J].中国免疫学杂志,2007,23(3):263-266. 被引量:6
  • 5Stomi T, Kundig TM, Senti G, et al. hnmunity in response to particulate antigen-delivery systems[ J]. Adv Drug Deliv Rev,2005, 57(3) :333 -355.
  • 6Tiwari S,Goyal AK, Mishra N,et al. Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine [ J ]. J Control Release, 2009,140 ( 2 ) : 157 - 165.
  • 7Gregoriadis G, Allison AC. Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice [ J ]. FEBS Lett, 1974,45 ( 1 ) :71 - 74.
  • 8Yoshikawa T, Imazu S, Gao JQ, et al. Augmentation of antigenspecific immune responses using DNA-fusogenic liposome vaccine [ J ]. Biochem Biophys Res Commun, 2004,325 ( 2 ) : 500- 505.
  • 9Khatri K, Goyal AK, Gupta PN, et al. Surface modified liposomes for nasal delivery of DNA vaccine [ J]. Vaccine,2008,211(18) : 2 225 -2 233.
  • 10Okada E, Sasaki S, Ishii N, et al. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colonystimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cellmediated immune responses against HIV-1 antigens[ J]. J Immuno1,1997,159 (7) :3 638 - 3 647.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部